Peptide Certificates of Analysis: What the HPLC and Mass Spectrometry Literature Reports

A certificate of analysis for a research peptide typically reports two different things that are measured by two different techniques: chromatographic purity, usually by reversed-phase HPLC with UV detection, and peptide content or identity, usually by some form of mass spectrometry. The published certification literature treats these as complementary rather than interchangeable measurements, and most reference-material papers describe running orthogonal methods against one another before a value is assigned [1][2][3]. Peptide content certification in the metrology literature is most often carried out by amino acid analysis after acid hydrolysis, with quantification by isotope dilution mass spectrometry (IDMS). In a laboratory study characterising naturally abundant and 13C-labelled synthetic angiotensin I, investigators hydrolysed the peptides and evaluated proline, leucine, isoleucine, valine, tyrosine, arginine, and phenylalanine for suitability as certification amino acids, quantifying by both LC-MS/MS and GC-MS/MS; a microwave-assisted procedure achieved complete hydrolysis in 150 minutes, and certified reference materials SRM 998 angiotensin I and CRM 6901-b C-peptide were used to validate the hydrolysis step [1]. A separate in vitro study applied gas chromatography–IDMS to [Glu1]-fibrinopeptide B, identified the principal impurity and used it to correct the final figure, and reported a purity of 0.715 ± 0.012 g/g with method repeatability of 0.5% and LODs of 0.041–0.096 μg/g [2]. That work reported accuracy comparable to liquid chromatography–IDMS [2]. The same approach has been used to produce certified peptide and protein materials. Aβ40 and Aβ42 solution certified reference materials were certified in vitro by isotope dilution HPLC-MS on hydrolysed amino acids and, orthogonally, by sulfur-based HPLC isotope dilution ICP-MS, yielding certified values of 7.58 ± 0.30 and 7.62 ± 0.30 μg/g; the study also reported homogeneity testing and stability for at least 5 days at −20 °C and 14 months at −70 °C [3]. A recombinant human growth hormone certified reference material was certified in vitro by amino acid analysis with isotope dilution HPLC-MS, cross-checked against microwave-assisted hydrolysis and against laboratories in Japan, China, and Korea; intact-protein analysis in that study showed degradation profiles above 4 °C even though the amino-acid-based content value was robust, which the authors tied to storage and dissemination conditions [4]. An element-specific variant of the same logic was applied to selenoprotein P in human plasma, where species-specific double isotope dilution with HPLC-ICP-MS/MS quantified selenium down to the peptide level, with results from two seleno-peptides agreeing within 2.4% and a relative expanded uncertainty of 5.4% [5]. Validation parameters that appear on well-documented analytical reports are described explicitly in these papers. A multiplex LC-MRM-MS reference measurement procedure for serum apolipoproteins was validated in human samples against ISO 15193:2009 for linearity, recovery, measurement uncertainty, precision, stability, carryover, limit of blank, limit of detection, limit of quantification, and comparability, reporting recovery of 99.2–100.3%, duplicate measurement uncertainty of 2.3%, and negligible matrix effects except in citrate plasma [6]. Transferability of a related multiplexed LC-MS/MS reference procedure across three calibration laboratories was assessed in six ring trials using shared calibrators, internal standards, and clinical samples, with median between-laboratory variation of 3.33–7.38% depending on the apolipoprotein and improving quality-control imprecision over time [7]. In food matrices, an LC-MS/MS assay for six immunogenic wheat gluten peptides reported LODs of 1–30 pg/mg, LOQs of 10–100 pg/mg, coefficients of determination consistently above 0.995, and spike recovery accuracy of roughly 90–98% across concentration levels, developed in part for gluten-free labelling and certification purposes [8]. Mass spectrometry also appears in the literature as the arbiter when an orthogonal assay disagrees. A non-competitive fluorescence immunoassay for HT-2 toxin was cross-validated in vitro by analysing a certified reference material and by HPLC-MS/MS [9]. Finally, one pharmaceutical study illustrates what a certificate can miss: glucagon obtained from a specific vendor underwent rapid peptide bond cleavage under near-neutral to basic conditions, monitored in vitro by HPLC with fragment structures confirmed by LC-MS, and the authors attributed it to a thermostable high-molecular-weight contaminant in the 10–30 kDa range introduced during manufacturing. They proposed that accelerated stability testing and accelerated stability criteria be included in certificates of analysis for sensitive reagents [10]. Read together, this body of work describes purity by HPLC, content by isotope dilution amino acid analysis, identity and impurity structure by LC-MS, and stability as a separately tested attribute rather than one inferred from a single chromatogram [1][2][3][4][10].